Navitas Semiconductor’s Legal Web Tightens as Patent Offensive Meets Counterclaims

The courtroom calendar at Navitas Semiconductor is starting to look as crowded as its product roadmap. The gallium nitride (GaN) chip specialist has now drawn itself into three separate legal battles in a matter of weeks — sometimes as the aggressor, sometimes as the defendant — just as its strategic pivot toward artificial intelligence infrastructure begins to show tangible results.

The latest move came on Monday, when Navitas filed suit against Renesas Electronics in the US District Court for the Eastern District of Texas. The complaint alleges that Renesas’s SuperGaN power semiconductors infringe four patents from the Navitas portfolio: US Patents 9,929,079, 11,545,838, 11,770,010 and 11,862,996. The company holds more than 300 patents in the GaN space, a technology widely viewed as critical for next-generation power conversion and efficiency.

A Two-Way Legal Street

The offensive against Renesas is not happening in a vacuum. Just weeks earlier, on July 22, Renesas turned the tables by suing Navitas and two of its employees — including CEO Chris Allexandre — in the Northern District of California, alleging trade secret misappropriation and breach of contract.

That case runs parallel to another filed in early July, when Wolfspeed brought claims against Navitas in Delaware, accusing the company of infringing five patents through its GaNFast, GaNSlim and GaNSafe product lines, as well as its GeneSiC components. Navitas has pushed back firmly, vowing to defend itself “with full force” against what it calls baseless accusations.

For investors, the legal tangle cuts both ways. A robust patent position signals competitive strength in a market where intellectual property is the primary moat. But US patent litigation is notoriously slow and expensive, and the uncertainty surrounding legal costs — not to mention the possibility of sales restrictions — tends to weigh on valuations. That dynamic, often described as a “litigation discount,” is now firmly embedded in how the market prices Navitas shares.

Market Sentiment Turns Cautious

The stock’s reaction to the Renesas lawsuit was telling. On Monday, Navitas shares fell 4.96 percent to close at €11.50 — a move that extended a downtrend in place since spring. The shares have now retreated 60.62 percent from their 52-week high of €29.20, reached in May 2026.

Tuesday brought some relief, with the stock trading at €11.80, up 2.61 percent. But even that bounce leaves the shares nearly 19 percent below their 50-day moving average of €14.55, suggesting the recent recovery has yet to break the medium-term bearish pattern.

Analysts remain cautious. In late July, both Morgan Stanley and Jefferies trimmed their price targets, to $12.60 and $13.00 respectively, with Jefferies maintaining a “Hold” rating. The consensus target now sits at €12.18, implying upside of roughly 5.9 percent from recent levels — hardly a ringing endorsement, but not a death sentence either. It reflects a market betting on the long-term value of the patent portfolio while discounting near-term legal risk.

Should investors sell immediately? Or is it worth buying Navitas Semiconductor Corporation?

The volatility profile adds another layer of caution. With annualized 30-day volatility at levels that place the stock firmly in the high-risk category, Navitas is not a name for the faint-hearted.

Operational Progress Beneath the Legal Noise

Beneath the legal headlines, the business is showing signs of life. In the second quarter of 2026, Navitas generated revenue of $10.5 million, up 22 percent sequentially — though still below the $14.5 million posted in the same period a year earlier.

The headline GAAP net loss of $228.2 million looks alarming at first glance, but the bulk of that figure — $203.1 million — stems from a non-cash revaluation of earnout obligations. On an adjusted basis, the loss came to $9.3 million, translating to a loss per share of $0.04, which beat the $0.05 analysts had penciled in.

Looking ahead, management guides for third-quarter revenue of $13.5 million, give or take $0.5 million — a sequential jump of roughly 28 percent — with adjusted gross margin expected around 39.7 percent.

The growth engine is the high-performance segment, which expanded more than 50 percent year over year in the second quarter. That surge is the direct payoff from the “Navitas 2.0” restructuring, which shifted the company’s focus away from mobile and consumer applications toward AI infrastructure, power grids and energy systems.

The balance sheet offers some comfort: cash reserves of $557 million provide ample runway for capacity investments. A technology partnership with Magnachip Semiconductor adds another dimension, giving the Korean chipmaker access to Navitas’s GeneSiC TAP technology while opening up the silicon carbide supply chain for grid, storage and industrial applications.

Insider Selling Adds to the Caution

One detail that has not gone unnoticed is the pattern of insider transactions. Over the past six months, several executives have sold rather than accumulated shares. Executive Ranbir Singh led the way, disposing of stock valued at over $100 million. CFO Todd Glickman and CEO Chris Allexandre also trimmed their positions, though in considerably smaller amounts.

For investors weighing the bull and bear cases, the picture is genuinely mixed. The operational turnaround is real, and the AI infrastructure push is gaining credibility. But the legal battles — three fronts and counting — inject a level of unpredictability that no spreadsheet can fully capture. Until the courts provide clarity, the stock may remain trapped in its volatile trading range, with the real value catalyst — a decisive legal victory and a strengthened GaN market position — still months, if not years, away.